NOVA MENTIS LIFE SCIENCES
Updated 33 days ago
700-838 West Hasting Street Vancouver, B.C. Canada V6C 0A6
Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) ("NOVA" or the "Company"), a biotechnology company and global leader in first-in-class psilocybin-based therapeutics and complementary diagnostics for neuroinflammatory disorders...
We're a Canadian-based biotechnology company and global leader in psilocybin-based therapeutics and complementary diagnostics for neuroinflammatory disorders. Our mission is to diagnose and treat debilitating chronic conditions that have unmet medical needs, such as autism spectrum disorder and fragile X syndrome...
Vancouver, British Columbia - January 03, 202 3 - Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) ("NOVA" or the "Company") announces the appointment of Dr. Georg Hochwimmer to the Company's Board of Directors, effective December 29, 2023.
Also known as: Nova, Nova Mentis Life Science Corp.
Associated domains: novamentisbiotech.com